Treatment of Borderline Phyllodes Tumors
Borderline phyllodes tumors should be treated with wide excision achieving negative surgical margins, with adjuvant radiotherapy reserved only for high-risk cases where clear margins cannot be achieved surgically. 1
Primary Surgical Management
Wide excision with clear margins is the definitive treatment for borderline phyllodes tumors. 1
- Target surgical margins of ≥1 cm to minimize local recurrence risk 1
- Either breast-conserving surgery or mastectomy can be performed, depending on tumor size and location 1
- No axillary staging or lymph node dissection is required, as phyllodes tumors rarely metastasize to lymph nodes 1
- Mastectomy is indicated only when adequate margins cannot be achieved with breast conservation 1
Margin Status and Re-excision
The most critical factor determining local recurrence is achieving negative margins 1:
- If margins are positive or <1 mm, repeat surgical excision should be performed to achieve clear margins 1
- Margins <1 cm are associated with heightened local recurrence risk but are not an absolute indication for mastectomy 1
- Recent evidence suggests that borderline tumors with margins ≤1 mm have increased recurrence risk 2
Role of Adjuvant Radiotherapy
In borderline phyllodes tumors, surgical excision alone is likely to be curative if negative margins are achieved. 1
Adjuvant radiotherapy should be considered only in high-risk cases of borderline phyllodes, specifically: 1
- Large tumors (>5 cm)
- Infiltrative margins
- Cases where clear margins could not be achieved surgically despite re-excision attempts
Evidence for Radiotherapy
- Adjuvant radiotherapy improves local control but not survival in breast sarcomas 1
- Meta-analysis data shows radiotherapy reduces local recurrence rates after breast-conserving surgery (HR=0.31) but not after mastectomy 3
- The UK guidelines (2025) specifically state radiotherapy is for improving local control when surgical margins are inadequate 1
Reconstruction Considerations
Immediate reconstruction should be avoided in borderline phyllodes tumors with high-risk features. 1
- Delayed reconstruction is preferred when primary oncological management is completed and local recurrence risk has diminished 1
- This approach is particularly important for large tumors that may require postoperative radiotherapy 1
Follow-up for Recurrence
Local recurrence occurs in approximately 7-24% of borderline phyllodes tumors, with most recurrences in patients who had positive or close margins initially 4, 5, 2
For locally recurrent disease: 1
- Re-excision with wide margins without axillary staging
- Consider postoperative radiation therapy, especially if additional recurrence would create significant morbidity 1
Key Clinical Pitfalls
Common diagnostic challenge: Core needle biopsy may not reliably distinguish borderline phyllodes from benign fibroadenoma preoperatively 1
Avoid these errors:
- Do not perform axillary staging—it is unnecessary and adds morbidity 1
- Do not use adjuvant chemotherapy or endocrine therapy—these have no proven role in borderline phyllodes 1
- Do not routinely recommend radiotherapy for all borderline tumors—reserve it for high-risk cases only 1
Multidisciplinary Management
Borderline phyllodes tumors should be referred to specialist sarcoma centers for pathology review and multidisciplinary team discussion. 1